Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the cell therapy market?

The size of the cell therapy market has expanded at a swift pace in the past few years. The market, which is forecasted to soar from $14.56 billion in 2024 to $17.02 billion in 2025, is expected to experience a compound annual growth rate (CAGR) of 16.9%. Factors contributing to the growth during the historical period include early research findings, regulatory breakthroughs, clinical trials and studies, the adoption by trailblazer businesses, and the receptiveness and perspective of the market.

What will be the cell therapy market size in the future?

The expectation is for the market size of supermarkets and hypermarkets to witness significant expansion in the coming years, reaching a value of $5414.75 billion in 2029, with a compounded annual growth rate (CAGR) of 7.3%. The acceleration predicted during this forecast period is due to factors such as the incorporation of e-commerce, health and wellness trends, initiatives towards sustainability, globalization trends, and innovations within store formats. Foreseen trends in this period are improved customer loyalty programmes, sourcing from local and regional markets, movements for contactless shopping, broadening of fresh and ready-to-eat products, and the application of data for inventory management.

Get your cell therapy market report here!

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

What main drivers are fueling expansion in the cell therapy market?

The escalating occurrence of chronic ailments has contributed to the growth of the cell therapy market. Chronic diseases, as defined by the US Centers for Disease Control and Prevention (CDC), are conditions that persist for over a year, necessitating medical care, limiting routine activities, or both. These include conditions like heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells offer potential benefits to patients suffering from conditions like spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), cardiovascular disease, cancer, and osteoarthritis. In July 2024, the Centers for Disease Control and Prevention (CDC), a U.S-based national public health institution, publicized significant advancements in their public health endeavors. Every year more than 944,800 Americans lose their lives to heart disease or stroke, representing over one-third of all deaths. In the U.S, close to 1.7 million people are diagnosed with cancer annually, and over 600,000 lose their lives to it, making it the second biggest killer. Moreover, over 38 million Americans are living with diabetes, and an additional 98 million adults are in the prediabetic stage, thus increasing their likelihood of developing type 2 diabetes. Diabetes can result in serious health issues like heart disease, kidney failure, and loss of vision. Obesity affects one in five children and 42% of adults, thereby increasing the risk of chronic diseases such as type 2 diabetes, cardiovascular disease, and select cancers. The escalating prevalence of chronic diseases has amplified the demand for cell therapies and boosted the growth of the cell therapy market.

What key areas define the segmentation of the global cell therapy market?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

Who are the dominant players expanding their reach in the cell therapy market?

Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

How are evolving market trends shaping cell therapy Strategies?

Primary market participants are tactically forming alliances and collaborations to grow the company’s range of products and territorial existence. Ajinomoto Co Inc., a food corporation based in Japan, acquired Forge Biologics for $620 million in November 2023. The goal of this acquisition is to strengthen Ajinomoto Co Inc.’s worldwide abilities in AAV and plasmid gene therapy production, enhancing and solidifying its existing contract development and production services. Forge Biologics is a biotechnology firm based in the US, concentrating on the evolution of cell therapy technologies for the treatment of various illnesses.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3393

Which regions are emerging as leaders in the cell therapy market?

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Anti-Viral Drug Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth

https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

Plasma Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Injectable Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: